These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7494503)

  • 1. Functional activities of antibodies directed against surface lipoproteins of Borrelia hermsii.
    Sambri V; Marangoni A; Massaria F; Farencena A; La Placa M; Cevenini R
    Microbiol Immunol; 1995; 39(8):623-7. PubMed ID: 7494503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of cysteine by Borrelia burgdorferi and Borrelia hermsii.
    Sambri V; Cevenini R
    Can J Microbiol; 1992 Oct; 38(10):1016-21. PubMed ID: 1477785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement.
    Sambri V; Armati S; Cevenini R
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):67-71. PubMed ID: 8364524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with the variable tick protein of the relapsing fever spirochete Borrelia hermsii protects mice from infection by tick-bite.
    Krajacich BJ; Lopez JE; Raffel SJ; Schwan TG
    Parasit Vectors; 2015 Oct; 8():546. PubMed ID: 26490040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies.
    Barbour AG; Bundoc V
    Infect Immun; 2001 Feb; 69(2):1009-15. PubMed ID: 11159997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of the outer membrane of Borrelia hermsii.
    Shang ES; Skare JT; Exner MM; Blanco DR; Kagan BL; Miller JN; Lovett MA
    Infect Immun; 1998 Mar; 66(3):1082-91. PubMed ID: 9488399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Borrelia-specific monoclonal antibody binds to a flagellar epitope.
    Barbour AG; Hayes SF; Heiland RA; Schrumpf ME; Tessier SL
    Infect Immun; 1986 May; 52(2):549-54. PubMed ID: 3516878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
    Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
    J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
    Belperron AA; Dailey CM; Bockenstedt LK
    J Immunol; 2005 May; 174(9):5681-6. PubMed ID: 15843569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.
    Gipson CL; de Silva AM
    Infect Immun; 2005 Mar; 73(3):1644-7. PubMed ID: 15731064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A murine IgG1 monoclonal antibody that binds specifically to outer surface protein A of Lyme disease spirochete Borrelia burgdorferi.
    Abolhassani M; Pavia CS; Dunn JJ; Chiao JW
    FEMS Microbiol Lett; 1993 May; 109(2-3):303-9. PubMed ID: 8339920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylated proteins in Borrelia hermsii, Borrelia parkeri, Borrelia anserina, and Borrelia coriaceae.
    Sambri V; Stefanelli C; Rossoni C; La Placa M; Cevenini R
    Appl Environ Microbiol; 1993 Nov; 59(11):3938-40. PubMed ID: 8285697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi.
    Liang FT; Jacobs MB; Philipp MT
    Infect Immun; 2001 Mar; 69(3):1337-43. PubMed ID: 11179296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
    Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
    J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides.
    Barstad PA; Coligan JE; Raum MG; Barbour AG
    J Exp Med; 1985 Jun; 161(6):1302-14. PubMed ID: 2409197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-heritable change of a spirochaete's phenotype by decoration of the cell surface with exogenous lipoproteins.
    Bunikis J; Mirian H; Bunikiene E; Barbour AG
    Mol Microbiol; 2001 Apr; 40(2):387-96. PubMed ID: 11309121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.
    Munson EL; Nardelli DT; Luk KH; Remington MC; Callister SM; Schell RF
    Clin Vaccine Immunol; 2006 Jan; 13(1):19-25. PubMed ID: 16425995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.
    Nardelli DT; Kevin Luk KH; Kotloski NJ; Warner TF; Torrealba JR; Callister SM; Schell RF
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):265-74. PubMed ID: 18522647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.